The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1

被引：66

作者：

Nauck, MA ^{[1
]}

El-Ouaghlidi, A ^{[1
]}

机构：

[1] Diabet Zentrum Bad Lauterberg, D-37431 Bad Lauterberg im Harz, Germany

来源：

DIABETOLOGIA | 2005年 / 48卷 / 04期

关键词：

dipeptidyl peptidase-IV; gastric inhibitory polypeptide; gastroenteropancreatic peptide hormones; glucagon-like peptide-1; incretin; incretin effect; oral hypoglycaemic agents; pharmacokinetics; proteolytic processing;

D O I：

10.1007/s00125-005-1704-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：608 / 611

页数：4

共 27 条

[1]

Ahren B, 2004, DIABETES, V53, pA83

[2] Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes [J].

Ahrén, B ;

Gomis, R ;

Standl, E ;

Mills, D ;

Schweizer, A .

DIABETES CARE, 2004, 27 (12) :2874-2880

[3] Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats [J].

Balkan, B ;

Kwasnik, L ;

Miserendino, R ;

Holst, JJ ;

Li, X .

DIABETOLOGIA, 1999, 42 (11) :1324-1331

[4] Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes [J].

Buse, JB ;

Henry, RR ;

Han, J ;

Kim, DD ;

Fineman, MS ;

Baron, AD .

DIABETES CARE, 2004, 27 (11) :2628-2635

[5]

Dardik B, 2003, DIABETES, V52, pA322

[6] Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs [J].

Deacon, CF ;

Wamberg, S ;

Bie, P ;

Hughes, TE ;

Holst, JJ .

JOURNAL OF ENDOCRINOLOGY, 2002, 172 (02) :355-362

[7] Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig [J].

Deacon, CF ;

Hughes, TE ;

Holst, JJ .

DIABETES, 1998, 47 (05) :764-769

[8] BOTH SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED GLUCAGON-LIKE PEPTIDE-I ARE RAPIDLY DEGRADED FROM THE NH2-TERMINUS IN TYPE-II DIABETIC-PATIENTS AND IN HEALTHY-SUBJECTS [J].

DEACON, CF ;

NAUCK, MA ;

TOFTNIELSEN, M ;

PRIDAL, L ;

WILLMS, B ;

HOLST, JJ .

DIABETES, 1995, 44 (09) :1126-1131

[9]

El-Ouaghlidi A, 2004, DIABETOLOGIA, V47, pA284

[10]

El-Ouaghlidi A, 2003, DIABETES, V52, pA118

← 1 2 3 →